Molecular Research Pharma CT Receives Seed Capital From CDP’s Southern Italy Business Fund
Molecular Research Pharma CT has received seed investment from CDP Venture Capital - National Innovation Fund of Italy’s "Italy Venture II - Southern Italy Business Fund." The fund aims to…